Core Viewpoint - The company has entered into a conditional equity transfer agreement to sell a 49% stake in Shanghai Shanshi Medical Beauty Hospital Co., Ltd. for a total consideration of RMB 73.598 million, which aligns with its strategy to optimize asset allocation and focus on core business development [1] Group 1: Transaction Details - The agreement involves Shanghai Huashi and Shanghai Lingfeng Medical, with Shanghai Lingfeng Medical agreeing to purchase the stake from Shanghai Huashi and the company's wholly-owned subsidiary, Shanghai Dajiankang Management [1] - Upon completion of the transaction, the company will no longer hold any equity in the target company, which will be fully owned by Shanghai Lingfeng Medical [1] Group 2: Strategic Implications - The sale allows the company to recover and reallocate capital, streamline its investment portfolio, and concentrate resources on its main business, thereby enhancing operational efficiency and capital discipline [1] - This transaction is part of the company's ongoing strategy to improve cash flow and support long-term sustainable growth [1]
上实城市开发(00563)：上海华氏及上实城开上海大健康管理拟7359.8万元出售上海上实医疗...